Coverage
-
January 18, 2017
A Massachusetts federal judge on Wednesday tacked on more than $21 million in interest to CardiAQ's enhanced trade secrets verdict against Neovasc over a transcatheter mitral valve, bringing the total award to over $111 million.
12 other articles on this case.
View all »